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The biotransformation of metals and metalloids into their volatile methylated derivatives by microbes growing under anaerobic
conditions(e.g.,themammalianintestinalmicrobiota)playsanimportantroleinspreadingthesecompoundsintheenvironment.
In this paper, we could show that the presence of an intact intestinal microbiota of mice provides the conditio sine qua non for the
production of these mostly toxic derivatives. To document the indispensible role of the intestinal microbiota in methylating metals
and metalloids to volatile derivatives under in vivo conditions, we compared the methylation capability of conventionally raised
(CONV) and germ-free (GF) B6-mice fed with chow containing colloidal bismuth subcitrate (CBS) as the starting material for the
formation of volatile methylated metal(loid)s. Permethylated volatile trimethylbismuth ((CH3)3Bi) was only detected in the blood
of the conventionally raised mice. Concomitantly, a higher bismuth concentration was found in organs such as liver, lung, testicles,
and brain of the CONV mice as compared to those of GF mice (P>0.01), strongly suggesting a correlation between the intestinal
biomethylation of bismuth and its accumulation in mammalian tissues.
1.Introduction
The biotransformation of metals and metalloids into their
volatile methylated derivatives raises ecological and health
concerns, since this process increases the toxicity and distri-
bution of the respective elements in our environment (e.g.,
As, Sb, Te, and Bi) [1–7]. Microorganisms, in particular
methanoarchaea growing under anaerobic conditions (e.g.,
in wetlands, lake sediments, sewage sludge, landﬁlls), are
responsible for this process [2, 8–12]. Recent reports of our
lab indicate that these transformations are also catalyzed
by microbiota originating from the mammalian intestine:
we detected the ex situ production of volatile metal(loid)s
in human feces samples and in contents of isolated gut
fragments of conventionally raised (but not of germ-free)
mice after ingestion of bismuth containing pharmaceuticals
[11] or in pure cultures of common gut methanoarchaea and
bacteria [13]. As the toxicity of trimethylbismuth (TMBi)
was found to be approximately two orders of magnitude
higher in comparison to inorganic bismuth both in animal
experiments [5]a sw e l la si nm o r er e c e n ts t u d i e so nc y t o t o x -
icity [4], the production of methylated bismuth species by
intestinal biomethylation is of potential health concern.
However, all studies to date concerning the role of the
intestinalmicrobiotainthemethylationofmetalsandmetal-
loids were performed under ex situ conditions, physiological
conditionswithinthelivingorganismshavebeendisregarded
so far. Our present study addresses this deﬁcit by analyz-
ing the role of the intestinal microbiota in transforming
metal(loid)s to volatile methylated derivatives in vivo by
comparative studies of conventionally raised (CONV) and
germ-free (GF) mice fed with colloidal bismuth subcitrate
(CBS) containing chow. After a feeding period of 14 days,
the formation of volatile bismuth compounds was followed
by determining their content in the blood of the animals
using purge-and-trap gas chromatography hyphenated to2 Journal of Toxicology
element-speciﬁc detection by inductively coupled plasma
mass spectrometry (PT-GC/ICP-MS). Moreover, the eﬀect
of the intestinal microbiocenosis on the uptake of bismuth
was studied by analyzing the total content of bismuth in the
organs. Conventionally raised mice, which were not fed with
bismuth containing chow, were used as control group.
Bismuth was used as model starting material for
metal(loid) methylation in the present study because of its
common presence in our environment due to its importance
in technological application (e.g., as additive in cosmetics,
catalysts, industrial pigments, alloys and ceramics [14]) and
in health care (as antimicrobial agent in pharmaceuticals for
the treatmentof peptic ulcerscaused by H. pylori). For a long
time, bismuth was thought to be a less toxic element but
since the 1970s it is well accepted that high-dosed medical
treatment with bismuth subgallate and subnitrate can cause
severe encephalopathies, renal failure, and genotoxic eﬀects
[15–17]. However, the clinical use of CBS does not appear to
cause neurotoxicity [18].
2.MaterialsandMethods
2.1. Handling and Feeding of the Mice. Feeding experiments
were conducted with CONV and GF B6-mice (Mus mus-
culus, males, ages 12 to 17 weeks). All experiments were
carried out in accordance with the German animal welfare
act for animal experiments. Animal husbandry for CONV
mice was performed by the Central Animal Laboratory of
the University Hospital Essen, and GF mice were bred in
the Animal Center of the University of Ulm and kept under
sterile conditions in a germ-free isolator.
The animals were housed individually in standard
M a c r o l o n ec a g e st y p eI I I( 3 8b y2 2b y1 5c m )w i t hS o f t w o o d
bedding material (type S 3/4, Sniﬀ GmbH, Soest, Germany)
under standard laboratory conditions (12-h light-12-h dark
cycle with lights on at 8a.m.; temperature, 21 +/− 1◦C;
relative humidity, 55% +/− 10%). Both CONV and GF
mice were fed with an autoclaved, standard diet enriched
with colloidal bismuth subcitrate (CBS) obtained from De-
Noltab (Yamanouchi Europe B.V., The Netherlands) with a
ﬁnal bismuth content of 50mgkg−1 (SNIFF V1534Bi, SNIFF
GmbH,Soest,Germany).Thedietandbottledtapwaterwere
available ad libitum. The bismuth uptake of mice during the
bismuth-enriched diet was calculated to be approximately
8.3mgkg1 day−1. Conventionally raised mice fed with a
autoclaved, commercial standard mouse diet without CBS
(SNIFF V1534) served as control animals.
The feeding experiments were conducted for 14 days in
three groups:
(i) CONV control mice (three individuals) fed with
standard diet,
(ii) CONV mice divided in 8 subgroups with 3 individu-
alseach(24CONVmicefedwithabismuth-enriched
diet),
(iii) GF mice divided in 7 subgroups with 3–5 individuals
each (28 GF mice fed with bismuth-containing
chow).
2.2. Sampling of Blood and Organ Tissues of the Mice. After
14 days of feeding with standard or CBS-containing diet, the
mice were anesthetized with a ketamine/xylazine-narcosis
(120mgkg−1 body weight or 13mgkg−1 body weight, resp.;
i.p.). The blood was extracted via cardiac puncture under
sterile conditions and transferred immediately into auto-
claved, helium-ﬁlled, and gas-tight-sealed 120mL glass vials
containing A. bidest with 1‰ anti-foaming agent (antifoam
289 Sigma-Aldrich, Taufkirchen, Germany) and heparin
(750IEmL−1, Ratiopharm, Ulm, Germany). To increase the
sample volume for a reliable determination of the volatile
derivative, the blood of three to ﬁve mice was pooled in
subgroupswithatotalvolumeof3-4mLblood.Aftercervical
dislocation, the mice were dissected and the organs (liver,
lung, kidneys, testicles, and brain) were removed and stored
at −80◦C until analysis of total bismuth concentration in
these tissues. Speciation analysis was performed within 12h
after sampling.
2.3. Speciation and Quantiﬁcation of Volatile Methylated Bis-
muth. The volatile bismuth in the headspace of the blood
samples was analyzed using a modiﬁed purge-and-trap gas
chromatographic system (PT-GC) coupled to an inductively
coupled plasma mass spectrometer (ICP-MS) (Fisons VG,
Plasma Quad II) as an element-speciﬁc detector as described
previously [8]. The bismuth species eluting from the GC
column were detected online by ICP-MS at a mass/charge
ratio of m/z 209, and the identity of the detected volatile
species was ensured by boiling point chromatographic
retention time correlation (boiling point of (CH3)3Bi at
760mmHg = 108.8◦C resulting in a retention time of 150s
under the given conditions). The limit of detection (LOD)
of the analyte was calculated with the 3σ criterion based
on the noise of the baseline, that is 1.5fmol for bismuth.
The whole headspace of the vials (∼105mL depending on
the volume of the extracted blood) was purged and trapped
for ﬁve minutes. The completeness of the (CH3)3Bi removal
from the blood was veriﬁed by repetition of the purge and
trap procedure. The content of (CH3)3Bi was calculated per
g blood wet weight.
2.4. Total Metal Analysis of Organ Tissues. The bismuth con-
tent of the organs was determined after homogenizing
the tissues using the Microdismembrator S (Sartorius,
G¨ ottingen). The homogenates were dried at 110◦Ct oc o n -
stantweight.Aliquots(0.1to0.5g)ofthedriedhomogenates
were suspended in 4mL HNO3 (65%, subboiled) and
2mLH 2O2 (30%, Suprapur; Merck, Darmstadt, Germany),
digested in a microwave-accelerated reaction system (MARS
5; CEM, Kamp Lintfort, Germany) and analyzed by ICP-MS-
analysisasdescribedpreviously[11].Totalmetalcontentwas
referred to g dry weight. For statistics, the nonparametric
Mann-Whitney-Wilcoxon U test was used.
3. Results and Discussion
3.1. The Transformation of Bismuth to Its Permethylated Vola-
tile Derivative (CH3)3Bi in Mice Requires an Intact Intestinal
Microbiota. To evaluate the role of the intestinal microbiotaJournal of Toxicology 3
Table 1: (CH3)3Bi content in blood samples of CONV and GF mice fed with CBS containing chow and CONV control mice on standard
diet. The absolute limit of detection (LOD) for (CH3)3Bi based on the 3σ criterion was 1.5fmol, whereas the relative LOD was between 4.5
and 6fmolg−1.
CONV mice GF mice CONV control mice
Subgroup fmolg−1 (w. w.) Subgroup fmolg−1 (w. w.) Subgroup fmolg−1 (w. w.)
1 15.1 1 LOD 1 LOD
2 16.8 2 LOD 2 LOD
3 71.4 3 LOD 3 LOD
48 . 4 4 L O D
56 . 2 5 L O D
6 35.1 6 LOD
7 12.3 7 LOD
87 . 4
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Figure 1: Bismuth content (means ± SD (nmolg−1 d. w.)) of organ
tissues of CONV mice and GF mice fed with CBS containing chow
as well as that of the CONV control mice fed with a standard diet.
(Signiﬁcance levels: ∗∗∗P<0.001, ∗∗P<0.01.)
of mice in transforming metal(loid)s into their volatile
methylated derivatives under in vivo conditions, we deter-
mined the content of volatile bismuth compounds in the
blood of CONV mice (i.e., mice with intact intestinal
microbiota) compared to that of GF mice, both fed with
CBS-enriched chow. For that purpose, the blood of the
mice was extracted via cardiac puncture and analyzed for
volatile bismuth compounds after a feeding period of two
weeks. As shown in Table 1, permethylated (CH3)3Bi was the
only volatile compound and it could exclusively be found
in the blood of CONV fed with CBS-enriched chow mice.
Neither in the blood of GF mice fed with CBS-enriched
chow nor in the blood of CONV mice fed without CBS-
enriched chow (CONV control mice) (CH3)3Bi could be
observed. This result clearly indicates that the presence of the
intestinal microbiota is indispensible for the transformation
of metal(loid)s into their volatile-methylated derivatives.
Most probably, the microbiota itself is responsible for the
transformation under in vivo conditions as already suggested
by various ex situ analyses of cultures derived from the
intestinal microbiota [11, 13]. We cannot, however, exclude
that epithelial and/or mesenchymal cells of the mice partly
contribute to these transformation processes under in vivo
conditions implying, however, that the intact intestinal
microbiota induces such an activity.
Previous studies of intestinal biovolatilization of bismuth
in human fecal samples and in human breath after ingestion
of bismuth have shown an extremely high interindividual
variability of 5 [11] and, 3 orders of magnitude [19],
respectively. In this study, the variation of the (CH3)3Bi
content observed in the blood of the diﬀerent subgroups
of the CONV mice is in accordance with previous studies
[11] ranging from 6.2 to 71.4fmolg−1 w.w. with a mean
value of 21.6 ± 22.1fmolg−1 w.w. (n = 8). Considering the
highly standardized conditions of animal husbandry applied
in this study, this relatively high variability probably reﬂects
diﬀerences in the composition of the intestinal microbiota
and its metabolic activity across the test population.
3.2. Methylation of Bismuth Is Accompanied with an Accumu-
lation of Bismuth in Organ Tissues. To examine the impact
of the methylation on the absorption of bismuth by the
mammalian organism, which could cause toxic eﬀects of
the bismuth derivatization, the bismuth content of liver,
lung, kidneys, testicles, and brain of CONV and GF mice
was investigated by microwave digestion and subsequent
analysis by ICP-MS. Interestingly, the bismuth content of
all organ tissues tested was signiﬁcantly higher in CONV
mice as compared to GF mice (Figure 1), indicating that
the intestinal microbiocenosis increases the bioavailability
of bismuth from the intestine. While mobilization of bis-
muth by chelation would presumably play a major role in
this process, the formation of methylated bismuth species
produced in the CONV mice can signiﬁcantly contribute.
At ﬁrst, methylated metal(loid) species can more easily
permeate through cell membranes due to their higher
hydrophobicity—accumulated in the cell by internal com-
plexation with various compounds—and thus permanently4 Journal of Toxicology
detracted from the blood. Next, the formation of perme-
thylated trimethylbismuth proceeds via partly methylated
mono- and dimethyl bismuth, which are not accessible
via GC-ICP-MS due to their low volatility, but can also
contribute to the increased bioaccessibility of bismuth due
to biomethylation.
The comparably high content of bismuth in the kidneys
of both CONV mice and GF mice is probably due to the
fact that the main part of inorganic bismuth is excreted via
the urinary system in mammals [17]. In the organ tissues
of the CONV control mice fed with chow without bismuth
addition, only low amounts of bismuth close to the LOD
were detected as expected for ICP-MS-analysis.
4. Conclusion
The observation that only CONV mice possessing an intact
intestinal microbiota but not GF mice are able to transform
bismuth to its permethylated derivative (CH3)3Bi proves the
indispensableroleoftheintestinalmicrobiotainmethylating
metalsandmetalloidstotheirvolatilederivativesintheliving
organism.
The detection of volatile (CH3)3Bi in blood of CONV
mice fed with CBS containing chow could be of some
relevance for healthiness. Obviously, the methylation of
bismuth to its volatile derivative (CH3)3Bi promotes the
dispersal of the metal in the mammalian organism via the
blood resulting in a signiﬁcant accumulation of bismuth in
organ tissues, presumably due to its increased hydrophobic-
ity caused by methylation, which increases interactions with
and penetration of cell membranes. To evaluate the resulting
health risk, the bismuth species accumulated in tissues
throughout the organism and its inter- and intracellular
interactions has to be determined.
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